Results 161 to 170 of about 67,776 (202)
PHARMACOLOGY OF NEW PSYCHOACTIVE SUBSTANCES
, 2017 Farre, M, Torrens, M, Papaseit, E
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Design of New Psychoactive Substances
Current Pharmaceutical Design, 2022Francesco Paolo, Busardò, Simona, Zaami
openaire +2 more sources
The comprehensive investigation of the new psychoactive substances
Sudebno-meditsinskaya ekspertiza, 2016This article was designed to discuss the issues related to ensuring the methodological uniformity of investigations of the novel psychoactive substances based on the system of the newly established specialized laboratories. The authors propose the methodological approaches to the implementation of comprehensive chemical and pharmacological research ...
A I, Andreev +4 more
openaire +2 more sources
New psychoactive substances: Are there any good options for regulating new psychoactive substances?
International Journal of Drug Policy, 2017Advances in chemistry, technology, and globalization have contributed to the rapid development and diffusion of NPS (new psychoactive substances), creating perhaps the most serious challenge to the century-old international drug control system and to national systems.
Peter, Reuter, Bryce, Pardo
openaire +2 more sources
New Psychoactive Substances in Pediatric Patients
Pediatric Clinics of North America, 2017New psychoactive substances (NPS), namely cannabinoids, cathinones, and opioids, have surged in popularity among school-age children, resulting in serious morbidity and mortality globally. In the last decade, there has been a rapid evolution of NPS resulting in hundreds of new compounds.
Brandon J, Warrick +2 more
openaire +2 more sources
Potential neonatal toxicity of new psychoactive substances
Pharmacology & Therapeutics, 2023Cannabis, cocaine, 3,4-methylenedioxymethamphetamine, and lysergic acid diethylamide are psychoactive substances with a significant increase in consumption during the 21st century due to their popularity in medicinal and recreational use. New psychoactive substances (NPSs) mimic established psychoactive substances.
Ryoichi, Fujiwara +7 more
openaire +2 more sources
Reference materials for new psychoactive substances
Drug Testing and Analysis, 2011AbstractHistorically, the appearance of new psychoactive materials (and hence the requirement for new reference standards) has been relatively slow. This position has now changed, with 101 new psychoactive substances reported to EMCDDA‐Europol since 2006.
Roland P, Archer +2 more
openaire +2 more sources
New and Emerging Illicit Psychoactive Substances
Medical Clinics of North America, 2018Several novel psychoactive substances have emerged in recent years. Users are typically young men who use other substances. In the category of stimulants, cathinones ("bath salts") have predominated and can lead to agitation, psychosis, hyperthermia, and death.
Ryan, Graddy +2 more
openaire +2 more sources
New Zealand's regulation of new psychoactive substances
BMJ, 2014A response to the futility of trying to ban such substances as they appear Last year the New Zealand parliament passed the Psychoactive Substances Bill 2013, which the associate minister for health argued was “to protect New Zealanders, particularly young New Zealanders, from the harm caused by untested drugs and an unregulated market.”1 2 This ...
Jack, Newberry +3 more
openaire +2 more sources
The Toxicology of New Psychoactive Substances
Therapeutic Drug Monitoring, 2016New psychoactive substances (NPSs) are substitutes for classical drugs of abuse and there are now compounds available from all groups of classical drugs of abuse. During 2014, the number of synthetic cathinones increased dramatically and, together with phenylethylamines, they dominate the NPS markets in the European Union. In total, 31 cathinones and 9
Elli, Tyrkkö +2 more
openaire +2 more sources